DOI:
10.1055/s-00042229
Geriatrie up2date
LinksClose Window
References
Vranckx P, Valgimigli M, Eckardt L. et al.
Articles Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
Lancet 2019;
394: 1335-1343
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.